Amplitude Ventures

Amplitude Ventures focuses on creating, building, and growing precision medicine companies that develop groundbreaking treatments with the aim of transforming patients’ lives. They invest in companies at the intersection of biology and machine learning, seeking to enhance the quality and accuracy of diagnoses and to select the right treatment for the right patient. The firm takes a proactive approach to investing, often discovering, incubating, and funding innovation through their internal engine, Pre-Amp, which partners with academics and company builders globally. They aim to drive innovation from ideation to patient care. Amplitude Ventures is committed to the success of founders, patients, and investors. They emphasize fairness and transparency, focusing on aligning the interests of stakeholders to make a profound and lasting impact on patient care. Their strategy includes active participation in company building, as demonstrated by their involvement in Radiant Biotherapeutics, where they provided early-stage funding and operational support, including serving as the founding CEO. The firm distinguishes itself by having a team of passionate investors, trained scientists, and experienced entrepreneurs who have been in the shoes of the founders they back. They value excellence, transparency, and integrity, and focus on partnering with passionate founders and innovators to positively impact the patient journey. They actively build companies and see themselves as more than just investors, acting as entrepreneurs and scientists supporting companies from the ground up.

Cardiology, Drug discovery, I&I, Metabolic, Neurology, Neurovascular, Oncology, Rare diseases, Precision medicine

Thematische Schwerpunkte und Zielmarktsegmente von Interesse.